News mRNA licensing agreements surge 800% amid GSK lawsuits An 800% increase in licensing deal values indicates growing confidence in mRNA technology. Eve Thomas
Interviews Q&A: BARDA wants to back tech that can combat multiple infections, says director Phalguni Deswal